Di Li

Institution
National Astronomical Observatories of the Chinese Academy of Sciences

Country
China

Field
Aerospace & Astronomy

Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.

 

(Photo: The Paper)

AWARDS
  • Marcel Grossmann Award

Related articles

Cell Therapies Are Gaining Momentum In Asia, Says Lonza’s Kim Raineri

There is a healthy pipeline of cell therapies coming from Asia, says Mr. Kim Raineri, Business Director at Lonza Bioscience Singapore.

Why Do Indian Students Take Up Engineering Degrees?

Dr. Pushkar, a faculty member at BITS Pilani-Goa, discusses the reasons that motivate students to take up engineering degrees in India.

World First Hand, Foot And Mouth Vaccine Developed

Chinese researchers have developed the world's first ever vaccine against a strain of enterovirus that can cause hand, foot and mouth disease,

Merck & BeiGene To Co-Develop 2nd Gen BRAF Inhibitor

Merck Serono and BeiGene have agreed to co-develop a second-generation BRAF inhibitor for the treatment of cancer.

Australia-China Joint Water Research Center Launched In Beijing

A new joint research center between Australia and China will address water resources management issues faced by both countries.

China’s Science Foundation Sets Aside US$3.9 Billion For R&D In 2013

China's National Natural Science Foundation has set aside US$3.9 billion in funds for scientific R&D this year.

EBOS Group Limited Acquires Australian Pharma Distributor, Symbion

EBOS Group Limited announced this week details of a NZ$1.1 billion acquisition of Australia's Symbion.

ASLAN’s Pan-HER Inhibitor Shows Positive Data In Gastric Cancer PhII Study

ASLAN Pharma announced this week positive data with ASLAN001 in a gastric cancer Phase II study.

Japan Launches Public-Private Partnership To Fight Neglected Diseases

The Global Health Innovative Technology Fund, a new public-private partnership, is taking Japanese R&D to the global fight against infectious disease.